<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(1)</volume><submitter>Murshed I</submitter><funding>The University of Adelaide</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Owing to multimodal treatment and complex surgery, locally advanced rectal cancer (LARC) exerts a large healthcare burden. Watch and wait (W&amp;W) may be cost saving by removing the need for surgery and inpatient care. This systematic review seeks to identify the economic impact of W&amp;W, compared with standard care, in patients achieving a complete clinical response (cCR) following neoadjuvant therapy for LARC.&lt;h4>Methods&lt;/h4>The PubMed, OVID Medline, OVID Embase, and Cochrane CENTRAL databases were systematically searched from inception to 26 April 2024. All economic evaluations (EEs) that compared W&amp;W with standard care were included. Reporting and methodological quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS), BMJ and Ph</pubmed_abstract><journal>Annals of surgical oncology</journal><pagination>137-157</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11659367</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.</pubmed_title><pmcid>PMC11659367</pmcid><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Seow W</pubmed_authors><pubmed_authors>Bunjo Z</pubmed_authors><pubmed_authors>Bedrikovetski S</pubmed_authors><pubmed_authors>Murshed I</pubmed_authors><pubmed_authors>Sammour T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.</name><description>&lt;h4>Background&lt;/h4>Owing to multimodal treatment and complex surgery, locally advanced rectal cancer (LARC) exerts a large healthcare burden. Watch and wait (W&amp;W) may be cost saving by removing the need for surgery and inpatient care. This systematic review seeks to identify the economic impact of W&amp;W, compared with standard care, in patients achieving a complete clinical response (cCR) following neoadjuvant therapy for LARC.&lt;h4>Methods&lt;/h4>The PubMed, OVID Medline, OVID Embase, and Cochrane CENTRAL databases were systematically searched from inception to 26 April 2024. All economic evaluations (EEs) that compared W&amp;W with standard care were included. Reporting and methodological quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS), BMJ and Ph</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T21:45:21.889Z</modification><creation>2025-04-04T21:45:21.889Z</creation></dates><accession>S-EPMC11659367</accession><cross_references><pubmed>39181996</pubmed><doi>10.1245/s10434-024-16056-4</doi></cross_references></HashMap>